ASCEND LABORATORIES LLC — Metformin Importer Profile
Pharmaceutical Importer · #4 buyer for Metformin · $20.8M import value · 479 shipments · UNITED STATES · DGFT Verified
ASCEND LABORATORIES LLC is the #4 importer of Metformin from India with $20.8M in import value and 479 verified shipments. ASCEND LABORATORIES LLC holds a 2.7% market share in Metformin imports based in UNITED STATES. The company sources from 3 verified suppliers across 193 formulations shipped to 3 countries. Overall, ASCEND LABORATORIES LLC imports 25 pharmaceutical products worth $163.5M across 12 therapeutic categories.
ASCEND LABORATORIES LLC — Metformin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Metformin to ASCEND LABORATORIES LLC?
Verified from 479 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INVENTIA HEALTHCARE LIMITED | $12.8M | 287 | 61.7% |
| GRANULES INDIA LIMITED | $4.2M | 97 | 20.2% |
| ALKEM LABORATORIES LIMITED | $3.8M | 95 | 18.1% |
ASCEND LABORATORIES LLC sources Metformin from 3 verified Indian suppliers based on 479 customs records. The primary supplier is INVENTIA HEALTHCARE LIMITED accounting for 61.7% of imports.
How Does ASCEND LABORATORIES LLC Compare to Nearest Metformin Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | GRANULES PHARMACEUTICALS, INC. | UNITED STATES | $23.1M | 461 | $50.0K |
| 5 | ZENTIVA PHARMA GMBH | BELGIUM | $16.7M | 461 | $36.2K |
| 4 | ASCEND LABORATORIES LLC ★ | UNITED STATES | $12.4M | 248 | $50.0K |
| 6 | ASCEND LABORATORIES,LLC ★ | UNITED STATES | $11.8M | 237 | $50.0K |
| 8 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $10.2M | 203 | $50.0K |
ASCEND LABORATORIES LLC ranks #4 among 1,475 Metformin importers from India. Average shipment value of $50.0K compared to the market average of $98.9K. The closest competitors by value are GRANULES PHARMACEUTICALS, INC. and ZENTIVA PHARMA GMBH.
Where Does ASCEND LABORATORIES LLC Import Metformin To?
Destination countries from 479 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $20.7M | 477 | 99.5% |
| UNITED KINGDOM | $50.0K | 1 | 0.2% |
| UNITED STATES OF AMERICA | $50.0K | 1 | 0.2% |
ASCEND LABORATORIES LLC imports Metformin to 3 countries. The primary destination is UNITED STATES receiving 99.5% of shipments worth $20.7M.
What Metformin Formulations Does ASCEND LABORATORIES LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| METFORMIN HCL ER 500 MG 500S (TABLETS) | $855.5K | 18 |
| METFORMIN HCL ER 500 MG 100S (TABLETS) | $792.2K | 17 |
| METFORMIN HCL ER 500MG 500'S (TABLETS) (EACH TABLET CONTAIN METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500MG) | $773.8K | 18 |
| METFORMIN HCL ER 500 MG 100S TABLETS | $700.0K | 14 |
| METFORMIN HCL ER 500 MG 500S (TABLETS)NDC NO.67877-159-05 (METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500MG | $689.0K | 16 |
| METFORMIN HCL ER 500 MG 500S TABLETSNDC NO.67877-159-05 METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500 | $600.0K | 12 |
| METFORMIN HCL ER 500MG 500'S (EACH TABLET CONTAIN METFORMIN HYDROCHLORIDE EXTENDED RELEASED TABLETS USP 500MG ) | $600.0K | 12 |
| METFORMIN HCL ER 500 MG 500 S TABLETS NDC NO 67877 159 05 Each Tablet Contain Metformin Hydrochloride Exte | $591.5K | 12 |
| METFORMIN HCL ER 500 MG 500'S (TABLETS) NDC NO.67877-159-05 (Each Tablet Contain Metformin Hydrochloride Exte | $491.4K | 10 |
| PHARMACEUTICAL PRODUCTS: METFORMIN HCL ER TABS 750MG 100'S USA NDC No67877041401 | $435.6K | 11 |
ASCEND LABORATORIES LLC imports 193 distinct Metformin formulations from India. The top formulation is METFORMIN HCL ER 500 MG 500S (TABLETS) with 18 shipments worth $855.5K.
Regulatory Requirements: Importing Metformin into United States
What ASCEND LABORATORIES LLC and other importers must comply with to import Metformin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Metformin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Metformin from India and How Much Does ASCEND LABORATORIES LLC Import?
India exported $145.8M worth of Metformin through 15,000 shipments from 528 suppliers to 160 countries, serving 1,475 buyers globally. ASCEND LABORATORIES LLC imports $20.8M of this total, accounting for 2.7% of India's Metformin exports with 479 shipments from UNITED STATES. This is verified from 479 customs shipment records covering 193 distinct formulations.
What Is the Average Order Value for ASCEND LABORATORIES LLC's Metformin Imports?
ASCEND LABORATORIES LLC's average Metformin order value is $43.4K per consignment, based on 479 shipments totaling $20.8M. ASCEND LABORATORIES LLC is based in UNITED STATES and ranks #4 among all Metformin importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Metformin to ASCEND LABORATORIES LLC?
ASCEND LABORATORIES LLC sources Metformin from 3 verified Indian suppliers: INVENTIA HEALTHCARE LIMITED ($12.8M, 61.7%), GRANULES INDIA LIMITED ($4.2M, 20.2%), ALKEM LABORATORIES LIMITED ($3.8M, 18.1%). This is based on 479 customs records.
How Does ASCEND LABORATORIES LLC Compare to Other Metformin Importers?
ASCEND LABORATORIES LLC ranks #4 among 1,475 Metformin importers from India with a 2.7% market share. The top 3 importers are GRANULES PHARMACEUTICALS INC ($27.1M), GRANULES PHARMACEUTICALS, INC. ($23.1M), ZENTIVA PHARMA GMBH ($16.7M). ASCEND LABORATORIES LLC processed 479 shipments from UNITED STATES.
About ASCEND LABORATORIES LLC
ASCEND LABORATORIES LLC imports 25 products worth $163.5M. Beyond Metformin, top products include Cephalexin, Amlodipine, Gabapentin, Ibuprofen, Ezetimibe. View the complete ASCEND LABORATORIES LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metformin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metformin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ASCEND LABORATORIES LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ASCEND LABORATORIES LLC's capped import value divided by total capped export value for Metformin across all Indian exporters.
- 5.Verified Records: This page is backed by 479 individual customs records matching ASCEND LABORATORIES LLC importing Metformin, covering 193 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 160+ countries, 1,475+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metformin Import Data for ASCEND LABORATORIES LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for ASCEND LABORATORIES LLC's Metformin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ASCEND LABORATORIES LLC
Full Company Profile →
25 products · $163.5M total trade · 12 categories
ASCEND LABORATORIES LLC × Metformin
Verified from customs records
Company Overview
Top Products by ASCEND LABORATORIES LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ASCEND LABORATORIES LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metformin. For current order-level data, contact TransData Nexus.